eXoZymes, Inc. (EXOZ)

8.50 +0.07 (+0.83%) USD  |  NASDAQ  |  Jul 01, 16:00
8.50 0.00 (0.00%) After-Hours: 20:00
More

eXoZymes EPS Diluted (Quarterly) : -0.2802 for March 31, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for EXOZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
March 31, 2026 -0.2802
December 31, 2025 -0.3164
September 30, 2025 -0.2727
June 30, 2025 -0.2818
March 31, 2025 -0.2218
Date Value
December 31, 2024 -0.2194
September 30, 2024 -0.2649
June 30, 2024 -0.1626
December 31, 2023 -0.1313
December 31, 2022 -0.0468

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. -0.3737
Perspective Therapeutics, Inc. -0.2528
MiMedx Group, Inc. -0.0732
ABVC BioPharma, Inc. -0.0613
Endonovo Therapeutics, Inc. -0.0005

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -2.370M
Total Expenses (Quarterly) 2.370M
Enterprise Value 71.79M
Earnings Yield -13.54%
Normalized Earnings Yield -13.54